Description

Deltex Medical Group plc, established in 2000 and headquartered in Chichester, UK, specializes in the development, marketing, and distribution of oesophageal Doppler haemodynamic monitoring systems. These TrueVue-branded solutions are available across the United Kingdom, United States, Spain, Canada, and other international territories. The company's product line includes Esophageal Doppler Probes, which offer real-time insights into central vascular blood flow and fluid status by measuring blood velocities in the descending aorta. Loops graphically illustrates aortic blood flow velocity and pressure throughout each heartbeat, while High Definition Impedance Cardiography provides non-invasive monitoring of cardiac function and fluid balance for conscious patients. Additionally, PressureWave utilizes a pulse pressure waveform analysis algorithm, designed for use during patient instability or when the primary ODM mode is inaccessible. Deltex Medical also supports professional development with its Esophageal Doppler Simulator, allowing clinicians to refine their skills in probe insertion, focusing, and waveform interpretation in a controlled, non-patient environment. These sophisticated monitoring tools are crucial in various medical applications, including intensive care for COVID-19 patients, sepsis management, major surgical procedures (such as abdominal, laparoscopic, and spinal surgeries), cardiac interventions, trauma care, organ transplantation, and post-operative monitoring for acute kidney injury.